GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Orthofix Medical Inc (NAS:OFIX) » Definitions » Beneish M-Score

Orthofix Medical (Orthofix Medical) Beneish M-Score

: -2.37 (As of Today)
View and export this data going back to 1992. Start your Free Trial

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.37 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Orthofix Medical's Beneish M-Score or its related term are showing as below:

OFIX' s Beneish M-Score Range Over the Past 10 Years
Min: -3.36   Med: -2.71   Max: -0.12
Current: -2.37

During the past 13 years, the highest Beneish M-Score of Orthofix Medical was -0.12. The lowest was -3.36. And the median was -2.71.


Orthofix Medical Beneish M-Score Historical Data

The historical data trend for Orthofix Medical's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orthofix Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.64 -3.36 -2.84 -2.50 -2.37

Orthofix Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.50 -1.98 -2.34 -2.40 -2.37

Competitive Comparison

For the Medical Devices subindustry, Orthofix Medical's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orthofix Medical Beneish M-Score Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Orthofix Medical's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Orthofix Medical's Beneish M-Score falls into.



Orthofix Medical Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Orthofix Medical for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.954+0.528 * 1.1237+0.404 * 1.1869+0.892 * 1.6206+0.115 * 1.287
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0599+4.679 * -0.097207-0.327 * 1.3341
=-2.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $128.1 Mil.
Revenue was 200.415 + 184.006 + 187.016 + 175.204 = $746.6 Mil.
Gross Profit was 136.63 + 119.763 + 119.551 + 110.329 = $486.3 Mil.
Total Current Assets was $420.4 Mil.
Total Assets was $925.3 Mil.
Property, Plant and Equipment(Net PPE) was $159.1 Mil.
Depreciation, Depletion and Amortization(DDA) was $60.6 Mil.
Selling, General, & Admin. Expense(SGA) was $530.4 Mil.
Total Current Liabilities was $165.2 Mil.
Long-Term Debt & Capital Lease Obligation was $111.6 Mil.
Net Income was -22.174 + -28.857 + -39.426 + -60.938 = $-151.4 Mil.
Non Operating Income was -2.954 + -5.93 + -3.353 + -3.458 = $-15.7 Mil.
Cash Flow from Operations was -6.694 + 0.477 + -5.516 + -34.02 = $-45.8 Mil.
Total Receivables was $82.9 Mil.
Revenue was 122.229 + 113.996 + 118.07 + 106.418 = $460.7 Mil.
Gross Profit was 89.176 + 83.423 + 86.47 + 78.1 = $337.2 Mil.
Total Current Assets was $256.0 Mil.
Total Assets was $458.6 Mil.
Property, Plant and Equipment(Net PPE) was $58.2 Mil.
Depreciation, Depletion and Amortization(DDA) was $32.1 Mil.
Selling, General, & Admin. Expense(SGA) was $308.8 Mil.
Total Current Liabilities was $83.6 Mil.
Long-Term Debt & Capital Lease Obligation was $19.2 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(128.098 / 746.641) / (82.857 / 460.713)
=0.171566 / 0.179845
=0.954

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(337.169 / 460.713) / (486.273 / 746.641)
=0.731842 / 0.651281
=1.1237

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (420.443 + 159.06) / 925.315) / (1 - (255.99 + 58.229) / 458.629)
=0.373724 / 0.314873
=1.1869

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=746.641 / 460.713
=1.6206

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(32.056 / (32.056 + 58.229)) / (60.598 / (60.598 + 159.06))
=0.355053 / 0.275874
=1.287

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(530.395 / 746.641) / (308.776 / 460.713)
=0.710375 / 0.670213
=1.0599

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((111.639 + 165.223) / 925.315) / ((19.239 + 83.624) / 458.629)
=0.299208 / 0.224284
=1.3341

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-151.395 - -15.695 - -45.753) / 925.315
=-0.097207

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Orthofix Medical has a M-score of -2.37 suggests that the company is unlikely to be a manipulator.


Orthofix Medical Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Orthofix Medical's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Orthofix Medical (Orthofix Medical) Business Description

Traded in Other Exchanges
Address
3451 Plano Parkway, Lewisville, TX, USA, 75056
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries globally. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.
Executives
James F. Hinrichs director 3750 TORREY VIEW COURT, SAN DIEGO CA 92130
Puja Leekha officer: CECO & Interim CLO 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Geoffrey C Gillespie officer: VP, Controller, Interim CFO 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Kevin J. Kenny officer: President of Global Spine C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112
Shweta Maniar director C/O SEASPINE HOLDINGS CORP, 5770 ARMADA DRIVE, CARLSBAD CA 92008
Stuart Essig director 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
John J. Bostjancic officer: CFO C/O SEASPINE HOLDINGS CORPORATION, 2302 LA MIRADA DRIVE, VISTA CA 92081
Keith Valentine director, officer: President & CEO 7475 LUSK BLVD., SAN DIEGO CA 92121
Henneman John B Iii director 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Patrick L Keran officer: Chief Legal Officer 6725 MESA RIDGE RD., SUITE 100, SAN DIEGO CA 92121
Thomas A. West director C/O INTERSECT, INC., 1555 ADAMS DRIVE, MENLO PARK CA 94025
Michael E Paolucci director 7475 LUSK BLVD., SAN DIEGO CA 92121
Catherine M Burzik director
Rice Doug officer: CFO 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Kimberley A. Elting officer: Chief Legal Officer 3451 PLANO PARKWAY, LEWISVILLE TX 75056

Orthofix Medical (Orthofix Medical) Headlines

From GuruFocus